Drug combinations against Borrelia burgdorferi persisters in vitro: Eradication achieved by using daptomycin, cefoperazone and doxycycline

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Feng, Jie ^a   Auwaerter, Paul G ^b   Zhang, Ying ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CARBENICILLIN; CARBOMYCIN; CEFOPERAZONE; CEFTRIAXONE; CLARITHROMYCIN; CLOFAZIMINE; DAPTOMYCIN; DOXYCYCLINE; HYDROXYCHLOROQUINE; MICONAZOLE; OFLOXACIN; POLYMYXIN B; PROPIDIUM IODIDE; RIFAMPICIN; SULFAMETHOXAZOLE; SYBR GREEN I PROPIDIUM IODIDE; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM MICROCOLONY FORM; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; DRUG EFFICACY; IN VITRO STUDY; NONHUMAN; STAINING; COMBINATION DRUG THERAPY; DRUG EFFECTS; HUMAN; LYME DISEASE;

ANIMALIA; BORRELIA BURGDORFERI;

ANTI-BACTERIAL AGENTS; BORRELIA BURGDORFERI; CEFOPERAZONE; DAPTOMYCIN; DOXYCYCLINE; DRUG THERAPY, COMBINATION; HUMANS; LYME DISEASE;

EID: 84926341095     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117207     Document Type: Article

References (40)

1. CDC (2014) Lyme Disease website. Available: http://www.cdc.gov/lyme/. Accessed 2014 Sep 13.
2. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, et al. (2006) The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43: 1089-1134. doi: 10.1086/508667 PMID: 17029130
3. Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, et al. (2013) Treatment trials for post-Lyme disease symptoms revisited. Am J Med 126: 665-669. doi: 10.1016/j.amjmed.2013.02.014 PMID: 23764268
4. Berndtson K (2013) Review of evidence for immune evasion and persistent infection in Lyme disease. Int J Gen Med 6: 291-306. doi: 10.2147/IJGM.S44114 PMID: 23637552
5. Steere AC, Glickstein L (2004) Elucidation of Lyme arthritis. Nat Rev Immunol 4: 143-152. doi: 10.1038/nri1267 PMID: 15040587
6. Bockenstedt LK, Gonzalez DG, Haberman AM, Belperron AA (2012) Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy. J Clin Invest 122: 2652-2660. doi: 10.1172/JCI58813 PMID: 22728937
7. Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW (2008) Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrobial Agents and Chemotherapy 52: 1728-1736. doi: 10.1128/AAC.01050-07 PMID: 18316520
8. Diterich I, Rauter C, Kirschning CJ, Hartung T (2003) Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun 71: 3979-3987. doi: 10.1128/IAI.71.7.3979-3987.2003 PMID: 12819085
9. Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, et al. (2010) Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrobial Agents and Chemotherapy 54: 643-651. doi: 10.1128/AAC.00788-09 PMID: 19995919
10. Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, et al. (2012) Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One 7: e29914. doi: 10.1371/journal.pone.0029914 PMID: 22253822
11. Hodzic E, Imai D, Feng S, Barthold SW (2014) Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice. PLoS One 9: e86907. doi: 10.1371/journal.pone.0086907 PMID: 24466286
12. Straubinger RK, Summers BA, Chang YF, Appel MJ (1997) Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. Journal of clinical microbiology 35: 111-116. PMID: 8968890
13. Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, et al. (2008) A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70: 992-1003. doi: 10.1212/01.WNL.0000284604.61160.2d PMID: 17928580
14. Marques A, Telford SR III, Turk SP, Chung E, Williams C, et al. (2014) Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study. Clin Infect Dis 58: 937-945. doi: 10.1093/cid/cit939 PMID: 24523212
15. Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, et al. (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60: 1923-1930. doi: 10.1212/01.WNL.0000071227.23769.9E PMID: 12821734
16. Feng J, Wang T, Shi W, Zhang S, Sullivan D, et al. (2014) Identification of Novel Activity against Borrelia burgdorferi Persisters Using an FDA Approved Drug Library. Emerg Microb Infect July 2, 2014: 3, e49.
17. Brorson O, Brorson SH, Scythes J, MacAllister J, Wier A, et al. (2009) Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline. Proc Natl Acad Sci U S A 106: 18656-18661. doi: 10.1073/pnas.0908236106 PMID: 19843691
18. Sapi E, Bastian SL, Mpoy CM, Scott S, Rattelle A, et al. (2012) Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS One 7: e48277. doi: 10.1371/journal.pone.0048277 PMID: 23110225
19. Miklossy J, Kasas S, Zurn AD, McCall S, Yu S, et al. (2008) Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation 5: 40. doi: 10.1186/1742-2094-5-40 PMID: 18817547
20. Alban PS, Johnson PW, Nelson DR (2000) Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology 146 (Pt 1): 119-127. PMID: 10658658
21. Kersten A, Poitschek C, Rauch S, Aberer E (1995) Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother 39: 1127-1133. doi: 10.1128/AAC.39.5.1127 PMID: 7625800
22. Brorson O, Brorson SH (1998) In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection 26: 144-150. doi: 10.1007/BF02771839 PMID: 9646104
23. Lantos PM, Auwaerter PG, Wormser GP (2014) A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis 58: 663-671. doi: 10.1093/cid/cit810 PMID: 24336823
24. Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, et al. (2011) Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resistance 4: 97-113.
25. Hunfeld KP, Brade V (2006) Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. Wien Klin Wochenschr 118: 659-668. doi: 10.1007/s00508-006-0693-z PMID: 17160604
26. Xu J, Lu Y, Fu L, Zhu H, Wang B, et al. (2012) In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters. Int J Tuberc Lung Dis 16: 1119-1125. doi: 10.5588/ijtld.11.0752 PMID: 22691726
27. Vanden Bossche H, Marichal P, Gorrens J, Coene MC, Willemsens G, et al. (1989) Biochemical approaches to selective antifungal activity. Focus on azole antifungals. Mycoses 32 1: 35-52. doi: 10.1111/j.1439-0507.1989.tb02293.x PMID: 2561184
28. Casjens S (2000) Borrelia genomes in the year 2000. J Mol Microbiol Biotechnol 2: 401-410. PMID: 11075912
29. Pogliano J, Pogliano N, Silverman JA (2012) Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol 194: 4494-4504. doi: 10.1128/JB.00011-12 PMID: 22661688
30. Zhang Y (2014) Persisters, Persistent Infections and the Yin-Yang Model. Emerg Microb Infect (Nature Publishing Group) 3, e3. doi: 10.1038/emi.2014.3
31. Dhand A, Bayer AS, Pogliano J, Yang SJ, Bolaris M, et al. (2011) Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis 53: 158-163. doi: 10.1093/cid/cir340 PMID: 21690622
32. Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ (2014) Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model. The Journal of antimicrobial chemotherapy 69: 2148-2154. doi: 10.1093/jac/dku113 PMID: 24777900
33. Dever LL, Jorgensen JH, Barbour AG (1993) In vitro activity of vancomycin against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother 37: 1115-1121. doi: 10.1128/AAC.37.5.1115 PMID: 8517700
34. Morris CM, George A, Wilson WW, Champlin FR (1995) Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida. J Antibiot (Tokyo) 48: 67-72. doi: 10.7164/antibiotics.48.67
35. Murgia R, Cinco M (2004) Induction of cystic forms by different stress conditions in Borrelia burgdorferi. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 112: 57-62. doi: 10.1111/j.1600-0463.2004.apm1120110.x PMID: 14961976
36. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K (2004) Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230: 13-18. doi: 10.1016/S0378-1097(03)00856-5 PMID: 14734160
37. Li Y, Zhang Y (2007) PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother 51: 2092-2099. doi: 10.1128/AAC.00052-07 PMID: 17420206
38. Clinical and Laboratory Standards Institute (2007) Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100-S17 27: 154-161.
39. Feng J, Wang T, Zhang S, Shi W, Zhang Y (2014) An Optimized SYBR Green I/PI Assay for Rapid Viability Assessment and Antibiotic Susceptibility Testing for Borrelia burgdorferi. PLoS ONE 9(11): e111809. doi: 10.1371/journal.pone.0111809 PMID: 25365247
40. Shopov A, Williams SC, Verity PG (2000) Improvements in image analysis and fluorescence microscopy to discriminate and enumerate bacteria and viruses in aquatic samples. Aquatic Microbial Ecology 22: 103-110. doi: 10.3354/ame022103